Publications

  • González, J; Jatem, E; del Carpio, J; Castañeda, ZI; Abó, AI; Martín, ML; Segarra, A

    Epidemiological, clinical and prognostic issues in SARS-CoV-2 infection or vaccination-related glomerular disease: Our single-center experience

    Nefrologia 44 582-583. .

    [doi:10.1016/j.nefro.2023.10.006]

  • Valdivielso JM; Carriazo S; Martin M; Fernandez-Fernandez B; Bermudez-López M; Ortiz A

    Gender-specific risk factors and outcomes of hyperkalemia in CKD patients: smoking as a driver of hyperkalemia in men.

    CLINICAL KIDNEY JOURNAL 17 -. .

    [doi:10.1093/ckj/sfad212]

  • Navarro-Gonzalez, JF; Mora-Fernandez, C; Diaz-Tocados, JM; Bozic, M; Bermudez-Lopez, M; Martin, M; Valdivielso, JM

    Serum Phosphate Levels Modify the Impact of FGF23 Levels on Hemoglobin in Chronic Kidney Disease.

    Nutrients 14 -. .

    [doi:10.3390/nu14224842]

  • Roca, Neus; Jatem, Elias; Abo, Anabel; Santacana, Maria; Cruz, Alejandro; Madrid, Alvaro; Fraga, Gloria; Martin, Marisa; Gonzalez, Jorge; Martinez, Cristina; Balius, Anna; Segarra, Alfons

    CD44-negative parietal-epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcome.

    CLINICAL KIDNEY JOURNAL 15 545-552. .

    [doi:10.1093/ckj/sfab215]

  • Molina, M; Sorolla, C; Samsó, E; Carcaña, M; Martín, ML; Jatem, E; Pitarch, G; Montero, L; Lauzurica, R; Segarra, A

    Quality of Life in Long-Term Renal Transplant Patients: A Controversial Subject

    TRANSPLANTATION PROCEEDINGS 54 91-93. .

    [doi:10.1016/j.transproceed.2021.11.025]

  • Molina, M; Sorolla, C; Samsó, E; Carcaña, M; Martín, ML; Jatem, E; Pitarch, G; Montero, L; Lauzurica, R; Segarra, A

    Cost of Traveling to Follow-up Appointments at Kidney Transplant Clinics

    TRANSPLANTATION PROCEEDINGS 54 94-95. .

    [doi:10.1016/j.transproceed.2021.11.005]

  • Medrano AS; Muijsemberg A; Wimbury D; Martin M; Jatem E; González J; Colás-Campás L; García-Carrasco A; Martínez C; Barratt J

    Relationship between IgA1 lectin-binding specificities, mesangial C4d deposits and clinical phenotypes in IgA nephropathy.

    NEPHROLOGY DIALYSIS TRANSPLANTATION 37 318-325. .

    [doi:10.1093/ndt/gfaa356]

  • Jatem-Escalante, E; Martin-Conde, ML; Gracia-Lavedan, E; Benitez, ID; Gonzalez, J; Colas, L; Garcia-Carrasco, A; Martinez, C; Segarra-Medrano, A

    Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy

    CLINICAL KIDNEY JOURNAL 14 2556-2562. .

    [doi:10.1093/ckj/sfab116]

  • Del Carpio, J; Marco, MP; Martin, ML; Craver, L; Jatem, E; Gonzalez, J; Chang, P; Ibarz, M; Pico, S; Falcon, G; Canales, M; Huertas, E; Romero, I; Nieto, N; Segarra, A

    External validation of the Madrid Acute Kidney Injury Prediction Score

    CLINICAL KIDNEY JOURNAL 14 2377-2382. .

    [doi:10.1093/ckj/sfab068]

  • Buxeda, A; Arias-Cabrales, C; Perez-Saez, MJ; Cacho, J; Pelegrin, SC; Melilli, E; Aladren, MJ; Galeano, C; Lorenzo, I; Mazuecos, A; Saura, IM; Franco, A; Ruiz-Fuentes, MD; Sanchez-Camara, LA; Siverio, O; Martin, ML; Gonzalez-Garcia, E; Lopez, V; Martin-Moreno, PL; Moina, I; Berrio, EM; Moreso, F; Portoles, JM; Santana-Estupinan, R; Zarraga, S; Canal, C; Sanchez-Alvarez, E; Pascual, J; Crespo, M

    Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19

    Kidney International Reports 6 2305-2315. .

    [doi:10.1016/j.ekir.2021.06.023]

  • Carpio JD; Marco MP; Martin ML; Ramos N; de la Torre J; Prat J; Torres MJ; Montoro B; Ibarz M; Pico S; Falcon G; Canales M; Huertas E; Romero I; Nieto N; Gavaldà R; Segarra A

    Development and Validation of a Model to Predict Severe Hospital-Acquired Acute Kidney Injury in Non-Critically Ill Patients.

    Journal of Clinical Medicine 10 -. .

    [doi:10.3390/jcm10173959]

  • Roca N; Jatem E; Martín ML; Muñoz M; Molina M; Martínez C; Segarra A

    Relationship between soluble urokinase-type plasminogen activator receptor and serum biomarkers of endothelial activation in patients with idiopathic nephrotic syndrome.

    CLINICAL KIDNEY JOURNAL 14 543-549. .

    [doi:10.1093/ckj/sfz173]

Projects

  • Relación entre glicoformas de IgA1 e IgA2, actividad clínica y activación del complemento en la nefropatía IgA
  • Papel de la vía PI3K/AKT/mTOR en la regulación de las alteraciones del metabolismo mineral en la enfermedad renal crónica. Implicaciones en la regulación de la síntesis de FGF23.
  • Papel de la señalizacion renal por IGF en los eventos tempranos de la enfermedad renal crónica